skin cancer

Moderna/Merck begins late-stage study of skin cancer vaccine combination
Moderna/Merck begins late-stage study of skin cancer vaccine combination
Yahoo/Reuters
Moderna Therapeutics
Merck
MRNA
vaccines
skin cancer
Keytruda
clinical trials
Flag link:
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data
Yahoo/Reuters
ASCO 2023
Merck
Moderna Therapeutics
MRNA
vaccines
skin cancer
Flag link:
Turn Therapeutics Announces Positive In-Vivo Data for Non-Melanoma Skin Cancer Candidate
Turn Therapeutics Announces Positive In-Vivo Data for Non-Melanoma Skin Cancer Candidate
BioSpace
Turn Therapeutics
clinical trials
GX-03
basal cell carcinoma
skin cancer
Flag link:
Sanofi and Immunocore Pair High Potential Molecules for Metastatic Skin Cancers
Sanofi and Immunocore Pair High Potential Molecules for Metastatic Skin Cancers
BioSpace
Immunocore
Sanofi
clinical trials
SAR444245
skin cancer
Flag link:
Regeneron sees skin cancer potential beyond PD-1s with $250M Checkmate acquisition
Regeneron sees skin cancer potential beyond PD-1s with $250M Checkmate acquisition
Fierce Biotech
Regeneron
Checkmate Pharmaceuticals
M&A
skin cancer
vidutolimod
Flag link:
This Medical Device Company Is Changing the Game in Skin Cancer
This Medical Device Company Is Changing the Game in Skin Cancer
Motley Fool
devices
skin cancer
DermTech
diagnostics
Flag link:
Replimune heads for the liver
Replimune heads for the liver
EP Vantage
Replimune
oncolytic viruses
skin cancer
Flag link:
Bristol Myers details data for closely watched cancer immunotherapy
Bristol Myers details data for closely watched cancer immunotherapy
BioPharma Dive
ASCO 2021
immunotherapy
Bristol Myers Squibb
Opdivo
skin cancer
relatlimab
Flag link:
Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer
Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer
Yahoo/Benzinga
Sanofi
Regeneron
Libtayo
FDA
advanced basal cell carcinoma
skin cancer
Flag link:
Sanofi/Regeneron’s Libtayo set for new skin cancer use
Sanofi/Regeneron’s Libtayo set for new skin cancer use
Pharmaforum
Sanofi
Regeneron
Libtayo
clinical trials
skin cancer
Flag link:
Blow for Novartis as PD-1 drug spartalizumab flunks trial
Blow for Novartis as PD-1 drug spartalizumab flunks trial
Pharmaforum
Novartis
clinical trials
spartalizumab
skin cancer
Flag link:
Sanofi and Regeneron's I-O med Libtayo, on a roll, puts up basal cell carcinoma win
Sanofi and Regeneron's I-O med Libtayo, on a roll, puts up basal cell carcinoma win
Fierce Pharma
Sanofi
Regeneron
Libtayo
basal cell carcinoma
skin cancer
clinical trials
Flag link:
Almirall strikes option deal to buy Bioniz and dermatology drug BNZ-1
Almirall strikes option deal to buy Bioniz and dermatology drug BNZ-1
Pharmaforum
Almirall
Bioniz
skin cancer
alopecia
BNZ-1
M&A
Flag link:
An immuno-oncology triplet from Roche shows promise in mouse models of several tumors
An immuno-oncology triplet from Roche shows promise in mouse models of several tumors
Fierce Biotech
Roche
targeted antibodies
breast cancer
colon cancer
skin cancer
Flag link:
Regeneron, Sanofi Win Approval for Their First Immuno-Oncology Drug
Regeneron, Sanofi Win Approval for Their First Immuno-Oncology Drug
Bloomberg
Regeneron
Sanofi
Libtayo
immuno-oncology
skin cancer
FDA
Flag link:
Biofrontera files for IPO to run skin cancer clinical trials
Biofrontera files for IPO to run skin cancer clinical trials
Fierce Biotech
Biofrontera
IPO
clinical trials
skin cancer
Flag link:
Will This Drug Kick-Start Regeneron Pharmaceuticals Shares?
Will This Drug Kick-Start Regeneron Pharmaceuticals Shares?
Motley Fool
Regeneron
Sanofi
cemiplimab
skin cancer
Flag link:
FDA approves Pfizer, German Merck immunotherapy for skin cancer
FDA approves Pfizer, German Merck immunotherapy for skin cancer
Yahoo/Reuters
FDA
Pfizer
Merck KGaA
skin cancer
metastatic Merkel cell carcinoma
avelumab
Flag link:
Novartis, Sun Pharma enter deal for oncology drug Odomzo
Novartis, Sun Pharma enter deal for oncology drug Odomzo
BioPharma Dive
Novartis
Sun Pharma
oncology
Odomzo
skin cancer
Flag link:
German Merck, Pfizer get FDA priority review for cancer drug
German Merck, Pfizer get FDA priority review for cancer drug
Yahoo/Reuters
Merck KGaA
Pfizer
FDA
Merkel cell carcinoma
skin cancer
avelumab
Flag link:

Pages